|
Volumn 329, Issue 5993, 2010, Pages 770-773
|
A boost for HIV vaccine design
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
ANTIGEN;
CD4 ANTIBODY;
GLYCOPROTEIN GP 120;
GLYCOPROTEIN GP 41;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MONOCLONAL ANTIBODY;
NEUTRALIZING ANTIBODY;
EPITOPE;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
ANTIBODY;
BIOASSAY;
HUMAN IMMUNODEFICIENCY VIRUS;
VACCINE;
ADAPTIVE IMMUNITY;
CLINICAL RESEARCH;
COMPLEX FORMATION;
CRYSTAL STRUCTURE;
DRUG DESIGN;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SCREENING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMORAL IMMUNITY;
IMMUNIZATION;
IMMUNOCOMPETENT CELL;
PRIORITY JOURNAL;
PROTEIN BINDING;
SHORT SURVEY;
VIRUS ISOLATION;
VIRUS NEUTRALIZATION;
VIRUS REPLICATION;
VIRUS STRAIN;
ANTIBODY COMBINING SITE;
B LYMPHOCYTE;
CHEMISTRY;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
NOTE;
PROTEIN ENGINEERING;
X RAY CRYSTALLOGRAPHY;
AIDS VACCINES;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEUTRALIZING;
B-LYMPHOCYTES;
BINDING SITES, ANTIBODY;
CRYSTALLOGRAPHY, X-RAY;
DRUG DESIGN;
EPITOPES;
HIV ANTIBODIES;
HIV ENVELOPE PROTEIN GP120;
HIV INFECTIONS;
HIV-1;
HUMANS;
PROTEIN ENGINEERING;
|
EID: 77955630528
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1194693 Document Type: Short Survey |
Times cited : (58)
|
References (14)
|